VERV•benzinga•
Verve Therapeutics Reports Clearance Of IND Application By FDA For VERVE-102 For Treatment Of Patients Living With Heterozygous Familial Hypercholesterolemia And/Or Premature Coronary Artery Disease
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 24, 2025 by benzinga